APRE - Aprea Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

APRE is currently covered by 1 analysts with an average potential upside of $29.57 (28.89%) from yesterday's end of day stock price of $3.64. Aprea Therapeutics activity chart has currently 7 price targets and 8 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.5% with an average time for these price targets to be met of 19 days.

Highest price target for APRE is $40, Lowest price target is $40, average price target is $40.

Most recent stock forecast was given by GREGORY RENZA from RBC on 16-Mar-2022. First documented stock forecast 29-Sep-2020.

Best performing analysts who are covering APRE - Aprea Therapeutics:

Jeffrey Hung Gregory Renza Madhu Kumar Jessica Fye

Currently, out of the existing stock ratings of APRE - 1 which are a Hold (100%)

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$76.36 (2097.80%)

1 years 8 months 18 days ago

0/2 (0%)

$60.8 (84.82%)



2 years 3 months 14 days ago

1/1 (100%)

$47.6 (10.52%)




$56.36 (1548.35%)


2 years 3 months 22 days ago

3/3 (100%)

$4 (3.03%)




$4.34 (657.58%)


2 years 11 months 5 days ago

1/2 (50%)

$5.86 (17.20%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APRE (Aprea Therapeutics) average time for price targets to be met?

On average it took 19 days on average for the stock forecasts to be realized with a an average price target met ratio 62.5

Which analyst has the current highest performing score on APRE (Aprea Therapeutics) with a proven track record?


Which analyst has the current lower performing score on APRE (Aprea Therapeutics) with a proven track record?


Which analyst has the most public recommendations on APRE (Aprea Therapeutics)?

Jeffrey Hung works at MORGAN STANLEY and has 5 price targets and 8 ratings on APRE

Which analyst is the currently most bullish on APRE (Aprea Therapeutics)?

Gregory Renza with highest potential upside - $76.36

Which analyst is the currently most reserved on APRE (Aprea Therapeutics)?

Jessica Fye with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart